"Designing Growth Strategies is in our DNA"

Lung Cancer Screening Market Size, Share & COVID-19 Impact Analysis, By Cancer Type (Non-small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer); By Diagnosis Type (Low Dose Spiral CT Scan, and Chest X-ray), By End-user (Hospitals & Clinics, and Diagnostic Centres), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI101174

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Request Sample PDF

Refresh Button
Lung Cancer Screening Market Size, Share and Global Industry Trend Forecast till 2025
  • Aug, 2021
  • 2020
  • 2017-2019
  • 139

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X